Regulation And Legal
Transgene Biotek SEBI Regulation 32(1) Non-Applicability Intimation
Transgene Biotek intimates BSE that SEBI Regulation 32(1) is not applicable for Q4 FY26.
Company confirms no public, rights, or preferential issue activity during the quarter ended March 31, 2026.
Fil
